Cardiology
Commentary
Organ transplantation: Unvaccinated need not apply
Pandemic-era physicians must now consider whether a politically motivated choice to decline COVID-19 vaccination should negatively affect the...
News
Sports experts on T2D: Boost activity, cut sedentary time
“Exercise can play an important role in managing type 2 diabetes, and workouts can be modified to fit the abilities of most people.”
News
Study questions need for repeat Lp(a) testing
A large cohort study finds that a baseline test for lipoprotein(a) can help determine cardiovascular disease risk and that repeat testing isn't...
Conference Coverage
New stroke risk score developed for COVID patients
The user-friendly score represents a step forward but also points to the need to better risk-stratify patients for this complex, expensive, and...
News
Biomarkers predict cardiovascular risk in chronic kidney disease patients
New models to stratify atherosclerotic cardiovascular disease risk may improve shared decision-making.
News
‘Substantial’ CVD risks, burden up to a year after COVID-19
Governments and health systems need to be prepared to deal with the likely significant contribution of the pandemic to a rising burden of...
Conference Coverage
Absolute increase in Kawasaki CV risk remains small in long-term follow-up
Relative to controls, the increased long-term cardiovascular risk of patients with Kawasaki disease is small in most patients.
News
No COVID vax, no transplant: Unfair or good medicine?
Is removing them from the list unfair and cruel, or simply business as usual?
News
Hong Kong, U.S., Israeli data illuminate COVID vaccine myocarditis
Prevalences, nuances of presentation, and likely clinical course of myocarditis after use of some vaccines against SARS-CoV-2 are in sharper view...
News
Uptake uncertain for potent new LDL-lowerer inclisiran
Inclisiran, a novel small interfering RNA drug that inhibits PCSK9, made its U.S. debut in early 2022 with cautious uptake prospects.